European Vaccine Initiative eV

European Vaccine Initiative eV is a research organisation in Heidelberg, Germany that has taken part in 21 EU-funded projects since 2016, receiving €13.7M in EU funding and leading 12 as coordinator.

EU funding received€13.7M
EU projects21
As coordinator12
Running now14
First EU project2016
Latest project2026
CountryGermany
EU registration (PIC)886899810
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are European Vaccine Initiative eV's own share of each project, not the project's full budget.

  • Horizon 2020€7.6M · 8 projects
  • Horizon Europe€6.1M · 12 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

21 EU-funded projects, newest first. European Vaccine Initiative eV led 12 of them as coordinator. Each links to the official record.

  • PREPAIR-VACCoordinator

    PREParedness using Artificial Intelligence for Rapid VACcine design

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €889ktheir share
  • WANETAM-4Partner

    West African Network of Excellence for TB, AIDS and Malaria

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €6ktheir share
  • ISIDORe IIPartner

    INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €296ktheir share
  • EVADEREAssociated partner

    Enhanced VAccines DEsign against antimicrobial REsistance

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • MVC-2GPartner

    Optimising a Deployable High Efficacy Multi-Stage Vaccine for Plasmodium falciparum Malaria: 2nd Generation Malaria Vaccine Consortium

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €50ktheir share
  • OPT-MVACPartner

    Optimizing the delivery and uptake of malaria vaccines in countries with areas of highly seasonal transmission in West and Central Africa

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €298ktheir share
  • LIVE_InnovAssociated partner

    Leading International Vaccinology Education for Innovation

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • DRAIGONCoordinator

    Diagnosing Infections with Multi-Drug Resistant Microorganisms using AI-powered Genomic Antibiotic Susceptibility Prediction from Long-Read Sequencing Data

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €843ktheir share
  • CAPTIVATECoordinator

    CorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €944ktheir share
  • NOSEVACCoordinator

    INNOVATIVE NASAL VACCINES TO PREVENT PATHOGEN COLONIZATION AND INFECTION IN THE UPPER RESPIRATORY TRACT

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €700ktheir share
  • UltiMalVaxCoordinator

    A Vaccine Targeting Eradication of Malaria

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €481ktheir share
  • ADVANCE-VAC4PMCoordinator

    Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building and Use Of Digital Health Technologies

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €1.3Mtheir share
  • ISIDORePartner

    Integrated Services for Infectious Disease Outbreak Research

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €302ktheir share
  • PrIMAVeRaCoordinator

    Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €1.2Mtheir share
  • Inno4VacCoordinator

    Innovations to accelerate vaccine development and manufacture

    Horizon 2020 · 2021–2028 · Project on CORDIS ↗

    €2.0Mtheir share
  • VACCELERATEPartner

    VACCELERATE - European Corona Vaccine Trial Accelerator Platform

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €543ktheir share
  • TRANSVAC-DSCoordinator

    DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €989ktheir share
  • SHIGETECVAXCoordinator

    Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €360ktheir share
  • SENETPartner

    Strengthening international R&I cooperations between China and the EU

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €137ktheir share
  • TRANSVAC2Coordinator

    European Vaccine Research and Development Infrastructure

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €1.3Mtheir share
  • VAC2VACCoordinator

    Vaccine lot to Vaccine lot comparison by consistency testing.

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

    €1.1Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • antibiotic resistance
  • artificial intelligence
  • bacteriology
  • big data
  • catalysis
  • coronaviruses
  • differential equations
  • drug resistance
  • emission spectroscopy
  • epidemiology
  • immunology
  • infectious diseases
  • influenza

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime